Protecting Americans with Preexisting Conditions Act of 2019 [HB-986]
[Healthcare ]
[Insurance ]
[Mental Health ]
[Public Health ]
(Sec. 3) nullifies guidance from the Department of the Treasury and the Department of Health and Human Services titled State Relief and Empowerment Waivers, published on October 24, 2018. The guidance pertains to Section 1332 waivers (also known as State Innovation Waivers or State Relief and Empowerment Waivers), which allow states to forego certain requirements of the Patient Protection and Affordable Care Act in order to implement experimental plans for health care coverage, as long as the resulting coverage meets certain statutory criteria.
(continued...)
HB-986: Protecting Americans with Preexisting Conditions Act of 2019
Sponsored by: Rep. Janice D. Schakowsky
Read The Second Time. Placed On Senate Legislative Calendar Under General Orders. Calendar No. 90. on 05/15/2019
HB-925: North American Wetlands Conservation Extension Act
Sponsored by: Rep. Mike Johnson
On Motion To Concur In The Senate Amendments With An Amendment Agreed To By The Yeas And Nays: 214 - 207 (roll No. 214). (text: Cr H5202-5417) on 10/01/2020
End Neglected Tropical Diseases Act [HB-826]
[Healthcare ]
[International ]
[Public Health ]
[Funding ]
[Grants ]
[Poverty ]
Expands programs to address neglected tropical diseases (NTDs), which are infections caused by pathogens, including viruses, microbes, and helminths (parasitic worms), that disproportionately impact individuals living in extreme poverty, especially in developing countries. Examples include dengue, leprosy, and rabies. The bill sets forth certain priorities for the NTDs Program of the U.S. Agency for International Development (USAID), including the coordination of program activities with other USAID development sectors regarding (1) education; (2)
(continued...)
HB-826: End Neglected Tropical Diseases Act
Sponsored by: Rep. Gregory W. Meeks
Referred To The Subcommittee On Health. on 02/12/2019
Middle Class Health Benefits Tax Repeal Act of 2019 [HB-748]
[Healthcare ]
[Finance ]
[Small Business ]
[Labor, Jobs, Employment ]
[Taxes ]
[Budget and Spending ]
[Public Health ]
[Education ]
[Medicare and Medicaid ]
[Unemployment ]
[Economic Development ]
[Funding ]
[Grants ]
[Insurance ]
[Technology and Innovation ]
[Telecommunications ]
[Consumer Protection ]
[Senior Citizens ]
[Pharmaceuticals ]
[Housing ]
[Real Estate ]
[Pensions ]
[Workers' Compensation ]
[Family-Related Legislation ]
[Children and Youth ]
[Data Privacy ]
[Cybersecurity ]
[Artificial Intelligence ]
[Science ]
[Law Enforcement ]
[National Security ]
[Military ]
[Defense ]
[Transportation and Motor Vehicles ]
[Air Quality ]
[Energy ]
[Trade ]
[Manufacturing ]
[Mental Health ]
[Overdose Prevention ]
[Property Tax ]
[Public Safety ]
[Retirement ]
[Veterans ]
[Community Development ]
[Disaster Relief ]
[Inflation ]
[Investments ]
[Poverty ]
[Social Security ]
[Climate Change ]
Responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses. DIVISION A--KEEPING WORKERS PAID AND EMPLOYED, HEALTH CARE SYSTEM ENHANCEMENTS, AND ECONOMIC STABILIZATION This division establishes the Paycheck Protection Program to provide eight weeks of cash flow assistance to small businesses through federally guaranteed loans to employers who maintain their payroll. Such assistance shall be to cover costs such as payroll, paid sick leave,
(continued...)
HB-748: Middle Class Health Benefits Tax Repeal Act of 2019
Sponsored by: Rep. Alexander Mooney
Committee On Small Business And Entrepreneurship. Hearings Held. on 07/23/2020
Gun Violence Prevention Research Act of 2019 [HB-674]
[Firearms/Gun Control ]
[Healthcare ]
[Public Health ]
[Science ]
[Crime ]
[Public Safety ]
Authorizes the Centers for Disease Control and Prevention to conduct or support research on firearms safety or gun violence prevention.
HB-674: Gun Violence Prevention Research Act of 2019
Sponsored by: Rep. Sean Patrick Maloney
Referred To The Subcommittee On Health. on 01/31/2019
Consolidated Appropriations Act, 2019 [HB-648]
[Agriculture ]
[Finance ]
[Environmental ]
[Infrastructure ]
[Housing ]
[Transportation and Motor Vehicles ]
[Budget and Spending ]
[Aerospace ]
[Food ]
[Healthcare ]
[Medicare and Medicaid ]
[Insurance ]
[Disaster Relief ]
[Funding ]
[Grants ]
Provides FY2019 appropriations for several federal departments and agencies. It includes 6 of the 12 regular FY2019 appropriations bills: the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; the Commerce, Justice, Science, and Related Agencies Appropriations Act, 2019; the Financial Services and General Government Appropriations Act, 2019; the Department of the Interior, Environment, and Related Agencies Appropriations Act, 2019; the Department of State, Foreign Operations, and Related
(continued...)
HB-648: Consolidated Appropriations Act, 2019
Sponsored by: Rep. Nita M. Lowey
Read The Second Time. Placed On Senate Legislative Calendar Under General Orders. Calendar No. 16. on 01/28/2019
Palliative Care and Hospice Education and Training Act [HB-647]
[Healthcare ]
[Education ]
[Public Health ]
[Science ]
[Funding ]
[Grants ]
[Human Services ]
[Medicare and Medicaid ]
Requires the Department of Health and Human Services (HHS) to take a series of actions relating to palliative-care training. Specifically, HHS must provide support for Palliative Care and Hospice Education Centers. The centers must improve the training of health professionals in palliative care and establish traineeships for individuals preparing for advanced-education nursing degrees, social-work degrees, or advanced degrees in physician-assistant studies in palliative care. HHS may provide support to medical schools, teaching hospitals, and graduate
(continued...)
HB-647: Palliative Care and Hospice Education and Training Act
Sponsored by: Rep. Alexander Mooney
Received In The Senate And Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 10/29/2019
Disability Integration Act of 2019 [HB-555]
[Disabilities ]
[Healthcare ]
[Housing ]
[Insurance ]
[Human Services ]
[Community Development ]
Prohibits government entities and insurance providers from denying community-based services to individuals with disabilities that require long-term service or support that would enable such individuals to live in the community and lead an independent life. Specifically, these entities may not discriminate against such individuals in the provision of community-based services by such actions as imposing prohibited eligibility criteria, cost caps, or waiting lists or failing to provide a specific community-based service. Additionally, community-based
(continued...)
HB-555: Disability Integration Act of 2019
Sponsored by: Rep. Sean Patrick Maloney
Referred To The Subcommittee On The Constitution, Civil Rights, And Civil Justice. on 02/25/2019
Safe and Affordable Drugs from Canada Act of 2019 [HB-478]
[Healthcare ]
[Pharmaceuticals ]
[Consumer Protection ]
[Trade ]
[Public Health ]
Requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by
(continued...)
HB-478: Safe and Affordable Drugs from Canada Act of 2019
Sponsored by: Rep. Steve Cohen
Referred To The Subcommittee On Health. on 01/31/2019
Prescription Drug Price Relief Act of 2019 [HB-465]
[Healthcare ]
[Pharmaceuticals ]
[Medicare and Medicaid ]
[Consumer Protection ]
[Public Health ]
Establishes a series of oversight and disclosure requirements relating to the prices of brand-name drugs. Specifically, the bill requires the Department of Health and Human Services (HHS) to review at least annually all brand-name drugs for excessive pricing; HHS must also review prices upon petition. If any such drugs are found to be excessively priced, HHS must (1) void any government-granted exclusivity; (2) issue open, nonexclusive licenses for the drugs; and (3) expedite the review of corresponding applications for generic drugs and biosimilar
(continued...)
HB-465: Prescription Drug Price Relief Act of 2019
Sponsored by: Rep. Barbara Lee
Referred To The Subcommittee On Health. on 01/31/2019
Affordable Limited Health Coverage Act [HB-458]
[Healthcare ]
[Insurance ]
[Medicare and Medicaid ]
[Public Health ]
Nullifies a rule by the Departments of the Treasury, Labor, and Health and Human Services regarding short-term, limited-duration health insurance plans that was published on October 31, 2016. The departments must use the definition of short-term, limited-duration insurance in use immediately prior to publication of the rule. (The rule requires the duration of short-term, limited-duration insurance to be less than three months, including renewals. Previously, such insurance was required to expire less than 12 months after its effective date.) Short-term,
(continued...)
HB-458: Affordable Limited Health Coverage Act
Sponsored by: Rep. Jeff Fortenberry
Referred To The Subcommittee On Health. on 03/01/2019
Affordable and Safe Prescription Drug Importation Act [HB-447]
[Healthcare ]
[Pharmaceuticals ]
[Consumer Protection ]
[Trade ]
[Public Health ]
Addresses the importation of drugs from Canada and other foreign countries. The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries. The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.
HB-447: Affordable and Safe Prescription Drug Importation Act
Sponsored by: Rep. Barbara Lee
Referred To The Subcommittee On Health. on 01/31/2019
Safe RESEARCH Act Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act [HB-437]
[Healthcare ]
[Science ]
[Reproductive Rights / Abortion ]
[Public Health ]
Prohibits the use of tissue from an induced abortion in research conducted or supported by the National Institutes of Health (NIH). Research with human fetal tissue or alternatives to human fetal tissue (e.g., stem cells) conducted or supported by the NIH must meet requirements currently applied only to research on the transplantation of human fetal tissue for therapeutic purposes, including requirements for the informed consent of the donor and researcher. Research conducted or supported by the NIH may use human fetal tissue only if the tissue
(continued...)
HB-437: Safe RESEARCH Act Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act
Sponsored by: Rep. Alexander Mooney
Referred To The Subcommittee On Health. on 01/31/2019
National Gun Violence Research Act [HB-435]
[Firearms/Gun Control ]
[Science ]
[Public Health ]
[Crime ]
[Funding ]
[Grants ]
[Public Safety ]
Amends various provisions of law and sets forth new provisions to promote gun violence research. Among other things, the bill does the following: removes limitations on the use of firearms tracing data by the Bureau of Alcohol, Tobacco, Firearms and Explosives; permits funds made available to the Department of Health and Human Services to be used for gun violence research; establishes the National Gun Violence Research Program to promote gun violence research; and authorizes various competitive grants to support research into the nature, causes,
(continued...)
HB-435: National Gun Violence Research Act
Sponsored by: Rep. Raul M. Grijalva
Referred To The Subcommittee On Research And Technology. on 02/12/2019
Neuromyelitis Optica Consortium Act [HB-321]
[Healthcare ]
[Science ]
[Public Health ]
[Funding ]
[Grants ]
[Disabilities ]
Requires the National Institutes of Health to establish, administer, and coordinate a national consortium on neuromyelitis optica (NMO), which is a neurological disease that can cause blindness and paralysis. The consortium must award grants for research on the causes of, and the risk factors and biomarkers associated with, NMO; assemble a panel of experts to provide guidance and recommendations on research design and protocols; and designate a central laboratory to collect and analyze data from this research and to make the data and analysis available
(continued...)
HB-321: Neuromyelitis Optica Consortium Act
Sponsored by: Rep. Barbara Lee
Referred To The Subcommittee On Health. on 01/31/2019
Supplemental Appropriations Act, 2019 [HB-268]
[Budget and Spending ]
[Disaster Relief ]
[Agriculture ]
[Defense ]
[Environmental ]
[Energy ]
[Healthcare ]
[Housing ]
[Labor, Jobs, Employment ]
[Education ]
[Veterans ]
[Transportation and Motor Vehicles ]
[Funding ]
[Grants ]
[Immigration ]
[Public Health ]
[Human Services ]
Provides FY2019 appropriations to federal agencies, including supplemental appropriations for disaster assistance and continuing appropriations for agencies that are included in the seven FY2019 appropriations bills that have not been enacted. The bill provides $14.2 billion in FY2019 supplemental appropriations for expenses related to the consequences of recent wildfires, hurricanes, volcanos, earthquakes, typhoons, and other natural disasters. The bill designates the spending as emergency spending, which is exempt from discretionary spending limits.
(continued...)
HB-268: Supplemental Appropriations Act, 2019
Sponsored by: Rep. Nita M. Lowey
S.amdt.201 Considered By Senate. on 04/01/2019
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2019 [HB-266]
[Small Business ]
[Healthcare ]
[Budget and Spending ]
[Public Health ]
[Funding ]
[Grants ]
[Disaster Relief ]
[Economic Development ]
Responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak by providing additional funding for small business loans, health care providers, and COVID-19 testing. DIVISION A--SMALL BUSINESS PROGRAMS (Sec. 101) This division provides additional lending authority for certain Small Business Administration (SBA) programs in response to COVID-19. Specifically, the division increases the authority for (1) the Paycheck Protection Program, under which the SBA may guarantee certain loans to small businesses during the COVID-19 pandemic; and (2) advances
(continued...)
HB-266: Department of the Interior, Environment, and Related Agencies Appropriations Act, 2019
Sponsored by: Rep. Betty McCollum
Became Public Law No: 116-139. (txt | Pdf) on 04/24/2020
Medicaid Provisions and TANF Extenders Act of 2019 [HB-260]
[Healthcare ]
[Medicare and Medicaid ]
[Budget and Spending ]
[Funding ]
[Human Services ]
[Poverty ]
[Public Health ]
[Children and Youth ]
Reauthorizes and revises several Medicaid programs and funding mechanisms, as well as the Temporary Assistance for Needy Families (TANF) program. Specifically, the bill makes appropriations for FY2019 for, and otherwise revises, the Money Follows the Person Rebalancing Demonstration Program; temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home and community-based services; reduces the federal medical assistance percentage (i.e., federal matching rate) for states
(continued...)
HB-260: Medicaid Provisions and TANF Extenders Act of 2019
Sponsored by: Rep. Frank Pallone
Referred To The Subcommittee On Worker And Family Support. on 01/31/2019
FACT Act Federal Accountability in Chemical Testing Act [HB-249]
[Science ]
[Public Health ]
[Environmental ]
[Consumer Protection ]
Requires the reports of the Interagency Coordinating Committee on the Validation of Alternative Methods to include a description of the progress on the development and use of alternative methods for toxicological testing by participating federal agencies. Federal agencies that require or recommend toxicological testing must provide the committee with necessary information.
HB-249: FACT Act Federal Accountability in Chemical Testing Act
Sponsored by: Rep. Barbara Lee
Referred To The Subcommittee On Health. on 01/31/2019
National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019 [HB-220]
[Healthcare ]
[Public Health ]
[Science ]
Establishes the Office of Oversight and Coordination for Tick-Borne Diseases within the Department of Health and Human Services (HHS). The office must oversee the creation of a national strategy to address Lyme disease and other tick-borne diseases and disorders. The national strategy must include program assessments, benchmarks for progress, and recommendations from the previously established Tick-Borne Disease Working Group. The bill also requires HHS to undertake specific actions that promote research, prevention, and treatment of Lyme disease
(continued...)
HB-220: National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019
Sponsored by: Rep. Sean Patrick Maloney
Referred To The Subcommittee On Health. on 01/31/2019